LON:HLN Haleon (HLN) Share Price, News & Analysis → Central Banks Preparing for US Dollar Collapse? (From Behind the Markets) (Ad) Free HLN Stock Alerts GBX 331.30 +1.30 (+0.39%) (As of 04:36 AM ET) Add Compare Share Share Today's Range 330.43▼ 334.2050-Day Range 312.05▼ 332.1952-Week Range 306.80▼ 357.65Volume735,555 shsAverage Volume19.15 million shsMarket Capitalization£30.25 billionP/E Ratio3,011.82Dividend Yield1.81%Price TargetGBX 357.60 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsDividendHeadlinesInsider TradesStock AnalysisAnalyst ForecastsChartCompetitorsDividendHeadlinesInsider Trades Get Haleon alerts: Email Address Haleon MarketRank™ Stock AnalysisAnalyst RatingHold2.00 Rating ScoreUpside/Downside8.4% UpsideGBX 357.60 Price TargetShort InterestN/ADividend StrengthWeakBased on Four FactorsSustainabilityN/ANews Sentiment0.30Based on 2 Articles This WeekInsider TradingSelling Shares£7.75 M Sold Last QuarterProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.20 out of 5 stars 1.0 Analyst's Opinion Consensus RatingHaleon has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on 1 buy rating, no hold ratings, and 1 sell rating.Price Target Upside/DownsideAccording to analysts' consensus price target of GBX 357.60, Haleon has a forecasted upside of 8.4% from its current price of GBX 330.Amount of Analyst CoverageHaleon has received no research coverage in the past 90 days. Previous Next N/A Short Interest Short InterestThere is no current short interest data available for HLN. Previous Next 0.8 Dividend Strength Dividend YieldHaleon pays a meaningful dividend of 1.84%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthHaleon does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Haleon is 5,454.55%. Payout ratios above 75% are not desirable because they may not be sustainable. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for HLN. Previous Next 2.4 News and Social Media Coverage News SentimentHaleon has a news sentiment score of 0.30. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.65 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Haleon this week, compared to 1 article on an average week.Search Interest15 people have searched for HLN on MarketBeat in the last 30 days. This is an increase of 114% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Haleon insiders have sold more of their company's stock than they have bought. Specifically, they have bought GBX 0 in company stock and sold £77,525.56 in company stock.Percentage Held by Insiders22.53% of the stock of Haleon is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 31.61% of the stock of Haleon is held by institutions. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Haleon is 3,000.00, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 143.11.Price to Earnings Ratio vs. SectorThe P/E ratio of Haleon is 3,000.00, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 255.14.Price to Earnings Growth RatioHaleon has a PEG Ratio of 1.69. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioHaleon has a P/B Ratio of 1.83. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad DTIWarning: this could blow your mindBuckle up… ‘Cause this might shatter everything you’ve heard about “income trading”. In fact, it’s such an extreme diversion from what most people think of typical income trades that I call it: The Perfect Income Trade You see, most of the income techniques out there target a couple of percent. Maybe 5 - 10 percent if you’re lucky. But this new way of trading income on the world’s top stocks goes after more than 10x that kind of return. And here’s the best news of all: This trade can target an opportunity like that every week. Every single week. Meaning an investor has the chance to “stack up” these more aggressive income trades over and over. If that sounds interesting…Watch the presentation here About Haleon Stock (LON:HLN)Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands includes Advil, Sensodyne, Panadol, Voltaren, Theraflu, Otrivin, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Weybridge, the United Kingdom.Read More HLN Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart HLN Stock News HeadlinesMarch 27, 2024 | americanbankingnews.comHaleon (LON:HLN) Trading Down 1.2%March 22, 2024 | nasdaq.comHLN Factor-Based Stock AnalysisMarch 28, 2024 | Insiders Exposed (Ad)This consistently signaled gains of 453%... 610%... and even 1036%...It doesn’t happen often, but occasionally, something completely unique comes across my radar. In this case, I’m talking about legal “Insider Trading”. Traders who have consistently signaled 453% … 610% .. and even 1036%... gains. And until now they have been doing it completely under the radar. In an upcoming interview I am revealing the strategy behind this gold-mine and how you can piggy back their every trade.March 18, 2024 | ca.finance.yahoo.comPrepare for Takeoff With PerrigoMarch 18, 2024 | finance.yahoo.comPfizer Plans to Sell About £2 Billion of Shares in HaleonMarch 13, 2024 | finance.yahoo.comHaleon PLC's Dividend AnalysisMarch 6, 2024 | insidermonkey.comHaleon plc (NYSE:HLN) Q4 2023 Earnings Call TranscriptMarch 1, 2024 | msn.comHaleon plc reports FY resultsMarch 28, 2024 | Insiders Exposed (Ad)This consistently signaled gains of 453%... 610%... and even 1036%...It doesn’t happen often, but occasionally, something completely unique comes across my radar. In this case, I’m talking about legal “Insider Trading”. Traders who have consistently signaled 453% … 610% .. and even 1036%... gains. And until now they have been doing it completely under the radar. In an upcoming interview I am revealing the strategy behind this gold-mine and how you can piggy back their every trade.February 29, 2024 | msn.comHere’s why the Haleon share price jumped 6% higher todayFebruary 29, 2024 | markets.businessinsider.comHaleon Annual Pre-tax Profit, Revenue ImproveFebruary 29, 2024 | msn.comConsumer health giant Haleon sees higher revenue in 2024February 17, 2024 | finance.yahoo.comHLN Mar 2024 10.000 callJanuary 25, 2024 | msn.comRobitussin Recall: Here Are The Products Impacted And What You Need To KnowJanuary 25, 2024 | reuters.comHaleon to recall batches of some adult cough syrups due to contaminationJanuary 25, 2024 | msn.comHaleon to sell ChapStick to Suave Brands for $430 million in cashJanuary 25, 2024 | finance.yahoo.comYellow Wood Partners Portfolio Company Suave Brands Company Acquires ChapStick from HaleonJanuary 24, 2024 | finance.yahoo.comHere’s Why Cooper Investors Sold Haleon plc (HLN)January 17, 2024 | msn.comGSK Cuts More Stake In Its Spun-Off Consumer-Healthcare Business Haleon, Raises Over £900MJanuary 17, 2024 | uk.investing.comGSK raises £978m through Haleon share saleJanuary 17, 2024 | reuters.comGSK raises $1.24 bln from latest Haleon stake saleJanuary 17, 2024 | msn.comGSK sells off partial stake in Haleon for $1.2BJanuary 16, 2024 | msn.comGSK to sell 3.2% stake in spinoff Haleon: reportDecember 11, 2023 | msn.comJeffries names Danone, Haleon and Henkel as three favorites in the European food and HPC sectorNovember 27, 2023 | msn.comHaleon plc - ADR (HLN) Price Target Increased by 5.59% to 9.45November 20, 2023 | benzinga.comHealth exclusion affects more than three in five people globallyNovember 20, 2023 | seekingalpha.comThe Investment Case For Haleon: Steady Shareholder Value AccumulationSee More Headlines Receive HLN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Haleon and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Ex-Dividend for 5/16 Dividend3/14/2024Today3/28/2024Dividend Payable5/16/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolLON:HLN CUSIPN/A CIKN/A Webwww.haleon.com Phone44 1932 822000FaxN/AEmployees24,622Year FoundedN/APrice Target and Rating Average Stock Price TargetGBX 357.60 High Stock Price TargetGBX 391 Low Stock Price TargetGBX 280 Potential Upside/Downside+8.4%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)GBX 0.11 Trailing P/E Ratio3,000.00 Forward P/E Ratio18.53 P/E Growth1.69Net Income£1.05 billion Net Margins9.28% Pretax MarginN/A Return on Equity6.70% Return on Assets4.28% Debt Debt-to-Equity Ratio57.42 Current Ratio1.04 Quick Ratio0.93 Sales & Book Value Annual Sales£11.30 billion Price / Sales2.67 Cash FlowGBX 15.03 per share Price / Cash Flow21.95 Book ValueGBX 180 per share Price / Book1.83Miscellaneous Outstanding Shares9,130,000,000Free FloatN/AMarket Cap£30.13 billion OptionableNot Optionable BetaN/A A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for April 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Brian James McNamara (Age 58)CEO & Executive Director Comp: $2.35MMr. Tobias Hannes Hestler (Age 52)CFO & Executive Director Comp: $999kMs. Sonya Ghobrial (Age 50)Head of Investor Relations Mr. Bjarne Philip Tellmann (Age 57)General Counsel Ms. Tamara Rogers (Age 54)Chief Marketing Officer Ms. Mairead Nayager (Age 49)Chief Human Resources Officer Mr. Filippo LanziPresident of EMEA & LatAmMr. Keith Choy (Age 55)President of Asia Pacific Ms. Lisa Paley (Age 57)President of North America Mr. Franck Riot (Age 56)Chief R&D Officer More ExecutivesKey CompetitorsSmith & NephewLON:SNGSKLON:GSKHikma PharmaceuticalsLON:HIKIndiviorLON:INDVHUTCHMEDLON:HCMView All CompetitorsInsidersTobias HestlerSold 23,564 sharesTotal: £7.75 M ($329.00/share)Manvinder Singh (Vindi) BangaBought 160,000 shares on 12/19/2023Total: £51.68 M ($323.00/share)View All Insider Transactions Should I Buy Haleon Stock? HLN Pros and Cons Explained These insights were generated using artificial intelligence. They are based on proprietary MarketBeat data, news articles, and custom LLM A.I. algorithms. This analysis of Haleon was last updated on Monday, March 25, 2024 at 10:55 AM. Pros Here are some ways that investors could benefit from investing in Haleon plc: Haleon plc engages in the research, development, manufacture, and sale of various consumer healthcare products globally, providing a diversified revenue stream. The company offers a portfolio of well-known brands like Advil, Sensodyne, Panadol, Voltaren, Theraflu, Otrivin, Polident, parodontax, and Centrum, which have strong market presence and consumer trust. Haleon plc recently announced a semi-annual dividend with a yield of 1.8%, indicating a commitment to rewarding shareholders. The company's stock price has shown stability and growth potential, with a 52-week low of $7.70 and a 52-week high of $9.05, reflecting positive market performance. Haleon plc has a market capitalization of $38.05 billion, indicating a sizable presence in the consumer healthcare industry. Cons Investors should be bearish about investing in Haleon plc for these reasons: The company's dividend payout ratio is currently 75.00%, which may indicate a significant portion of earnings being distributed as dividends rather than reinvested for growth. HLN Stock Analysis - Frequently Asked Questions Should I buy or sell Haleon stock right now? 2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Haleon in the last twelve months. There are currently 1 sell rating and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" HLN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in HLN, but not buy additional shares or sell existing shares. View HLN analyst ratings or view top-rated stocks. What is Haleon's stock price target for 2024? 2 brokers have issued 12-month price targets for Haleon's stock. Their HLN share price targets range from GBX 280 to GBX 391. On average, they expect the company's share price to reach GBX 357.60 in the next year. This suggests a possible upside of 8.4% from the stock's current price. View analysts price targets for HLN or view top-rated stocks among Wall Street analysts. How have HLN shares performed in 2024? Haleon's stock was trading at GBX 321.65 on January 1st, 2024. Since then, HLN stock has increased by 2.6% and is now trading at GBX 330. View the best growth stocks for 2024 here. How often does Haleon pay dividends? What is the dividend yield for Haleon? Haleon declared a dividend on Thursday, February 29th. Investors of record on Thursday, March 14th will be paid a dividend of GBX 4.20 per share on Thursday, May 16th. This represents a dividend yield of 1.34%. The ex-dividend date of this dividend is Thursday, March 14th. This is an increase from the stock's previous dividend of GBX 1.80. The official announcement can be accessed at this link. Read our dividend analysis for HLN. Is Haleon a good dividend stock? Haleon (LON:HLN) pays an annual dividend of GBX 6 per share and currently has a dividend yield of 1.84%. The dividend payout ratio is 5,454.55%. Payout ratios above 75% are not desirable because they may not be sustainable. Read our dividend analysis for HLN. How do I buy shares of Haleon? Shares of HLN stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:HLN) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBREAKING: New AI Breakthrough Could Change Healthcare ForeverBehind the Markets“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisorySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceBuy this small stock before coming AI Tidal WaveChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Haleon plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.